The U.S. Court of International Trade May 28 blocked a series of tariffs issued by the Trump administration under the International Emergency Economic Powers Act, a law granting the president authority to regulate various economic transactions following the declaration of a national emergency. The enjoined tariffs include the 10% universal tariffs for all countries and reciprocal tariffs on certain countries with which the U.S. has high trade deficits that were announced April 2. The court order also blocks tariffs imposed on Canada, Mexico and China in February that were based on concerns about illicit fentanyl trafficking. Tariffs imposed under other authorities such as Section 232 tariffs on steel and aluminum imports remain in place and were not impacted by yesterday’s ruling.

The Trump administration immediately filed a notice in the U.S. Court of Appeals for the Federal Circuit indicating that it will appeal this decision. The appeals court May 29 granted a temporary stay pending the appeal.

A second federal district court May 29 also found the Trump administration’s tariffs to be unlawful. The U.S. District Court for the District of Columbia held that IEEPA does not address tariffs at all and therefore does not grant the president the authority to impose such levies. The court issued a preliminary injunction against all tariffs imposed under the IEEPA. The administration is also expected to appeal this decision.

Related News Articles

Headline
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a…
Headline
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective…
Headline
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a…
Headline
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…